Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1326)	5/16/2002 1:50:44 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

Thursday May 16, 1:22 pm Eastern Time Press Release SOURCE: Patent Watch The U.S. Patent Office (PTO) Has Granted a Patent on Human Reproductive Cloning and the Embryos, Fetuses and Children That Would Be Created Through That Process Patent Watch Also Discloses Three Pending Patents Which Would Include Cloned Human Embryos and Fetuses Watch Dog Group Calls on the PTO and Congress to Halt Patenting of All Human Life Forms and Human Cloning Processes WASHINGTON, May 16 /PRNewswire/ -- Patent Watch, a public interest oversight group, announced today that it had uncovered a patent on human reproductive cloning and any "products" created by that process, theoretically including embryos, fetuses and children. The patent, U.S. Patent No. 6,211,429, was granted on April 3, 2001, but went unnoticed until Patent Watch discovered that the claims were applicable to human reproductive coning. The owner of the patent is the University of Missouri, but financial interest in the patent is shared by a Massachusetts biotech company Biotransplant Inc. Patent Watch also revealed today that it had uncovered three pending patents currently before the PTO that cover cloned human embryos and fetuses. * Patent application serial number 09/816,971, assigned to Geron Corp., which claims a "reconstituted animal embryo" described as having "its main use in ... mammalian embryos, particularly ruminant, human, or primate embryos;" * Patent application serial number 09/755,204, assigned to the Univ. of Connecticut, claiming any "animal" embryo made by a cloning process; and * Patent application serial number 09/828,876, assigned to the Univ. of Massachusetts and exclusively licensed to Advanced Cell Technology, claiming a mammalian "fetus obtained according to" a particularly specified cloning process. This patent application specifically contemplates the use of human tissues derived from cloned human embryos, fetuses, and offspring, for transplantation purposes. Commenting on the pending patents Patent Watch Project Director Peter DiMauro stated, "In deciding on these patents the PTO will be making an historic decision on the commodification of human life. They should reject these patents as violation of public policy." The PTO has the legal authority under both national and international law to reject patents that offend public morality or order but did not do so in the case of the Missouri patent. Nor does any current Congressional bill on human cloning halt the patenting of the process or its products. "This is not a slippery slope, rather this an ethical and legal free fall," stated Patent Watch Executive Director Andrew Kimbrell commenting on the Missouri patent. "The Patent Office has become a ghoulish human body shop allowing researchers and corporations to patent and own human body parts, cloning processes and even human life forms," Kimbrell continued. "The Patent Office and Congress must move quickly to halt this commodification of life and to ban all forms of human cloning," Kimbrell concluded. Patent Watch is a project of the International Center for Technology Assessment. CTA is a non-profit, bi-partisan organization committed to providing the public with full assessments and analyses of technological impacts on society, and is devoted to fully exploring the economic, ethical, social, environmental and political impacts that can result from the applications of technology or technological systems. SOURCE: Patent Watch